2.15 (-%)
As of Nov 01, 2024
Source:
Genprex, Inc is a clinical stage gene therapy company pioneering the development of gene-based therapies for large patient populations with unmet medical needs. Our oncology platform utilizes our non-viral ONCOPREX Nanoparticle Delivery System.
Country | United States |
Headquarters | austin, texas |
Phone Number | 512-537-7997 |
Industry | manufacturing |
CEO | J. Rodney Varner |
Website | genprex.com |